Cytek Biosciences (NASDAQ:CTKB – Get Rating) is one of 42 public companies in the “Analytical instruments” industry, but how does it weigh in compared to its peers? We will compare Cytek Biosciences to similar companies based on the strength of its dividends, institutional ownership, profitability, analyst recommendations, earnings, valuation and risk. Earnings & Valuation This […]